TM

Tomoya Miyakawa

CY Cytlimic: 8 patents #1 of 6Top 20%
NE Nec: 6 patents #2,374 of 14,502Top 20%
KU Kochi University: 4 patents #1 of 35Top 3%
Overall (All Time): #341,442 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
11759518 Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein Shun Doi, Koji Tamada 2023-09-19
11618770 MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka 2023-04-04
11491204 Composition comprising poly I:C and LAG-3-IGG fusion protein Shun Doi, Koji Tamada 2022-11-08
11304997 HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka 2022-04-19
11291718 Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein Shun Doi, Koji Tamada 2022-04-05
10875900 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka 2020-12-29
10842848 Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein Shun Doi, Koji Tamada 2020-11-24
10590179 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka 2020-03-17
10537626 HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka 2020-01-21
10526388 Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells Masaaki Oka, Shoichi Hazama, Koji Tamada, Keiko Udaka 2020-01-07
9353151 HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide Keiko Udaka 2016-05-31
9045531 HLA-binding peptide, precursor thereof, and DNA fragment and recombinant vector coding for said HLA-binding peptide Keiko Udaka 2015-06-02
8487076 HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide Keiko Udaka 2013-07-16
8324345 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same Keiko Udaka 2012-12-04